TG Therapeutics: Flawless Execution And $500 Million Non-Dilutive Capital Bolster Outlook [Seeking Alpha]
A Look At TG Therapeutics (TGTX) Valuation After Recent Share Price Momentum [Yahoo! Finance]
TG Therapeutics concludes enrolment in Phase III Briumvi trial [Yahoo! Finance]
TG Therapeutics Announces Completion of Enrollment for the Phase 3 Trial Evaluating Subcutaneous BRIUMVI [Yahoo! Finance]
TG Therapeutics Announces Completion of Enrollment for the Phase 3 Trial Evaluating Subcutaneous BRIUMVI